Molecular Analysis of the Cellular Ecosystem of Childhood Ependymoma

For pediatric brain cancer patients younger than 3 years old, ependymomas are one of the most common forms of central nervous system growth. With no effective chemotherapy currently available to treat ependymomas, there is a less than 55% 5-year survival rate in young patients. Researchers are seeking to build up the knowledge base around ependymomas and the mechanisms of their growth using RNA sequencing available through the Pediatric Brain Tumor Atlas. Greater understanding of ependymoma growth will guide the therapeutic decisions of medical professionals.